Oncology

Metastatic Breast Cancer

Conference Reporter® in HR+/HER2- Metastatic Breast Cancer to Cover Key Topics Being Presented at ASCO 2026

conference reporter by Komal Jhaveri, MD, FACP, FASCO

Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in HR+/HER2- Metastatic Breast Cancer presented at the 2026 ASCO Annual Meeting.

VIEW THE TOPICS:

Coming Soon.

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology.

2026 ASCO Annual Meeting

May 29 – June 2, 2026

McCormick Place

Chicago, IL

Registration Link

Profile

Komal Jhaveri, MD, FACP, FASCO

Associate Attending Physician, Breast Medicine and Early Drug Development Services
Section Head, Endocrine Therapy Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medicine
New York, NY

Oncology

Metastatic Breast Cancer

Conference Reporter® in HR+/HER2- Metastatic Breast Cancer to Cover Key Topics Being Presented at ASCO 2026

Komal Jhaveri, MD, FACP, FASCO

Explore More in Metastatic Breast Cancer

Expert Perspectives® in HR+/HER2- Metastatic Breast Cancer to Cover Key Topics in HR+/HER2- Metastatic Breast Cancer Treatment

HR+/HER2- Breast Cancer and the Problem of Resistance to Endocrine Therapies

Extending Overall Survival in HR+/HER2- Advanced Breast Cancer

Preserving Health-Related Quality of Life in Patients With Advanced Breast Cancer